MedTrace Logo

Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis

NCT02192164 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2017-06-28

Study results available
· View outcomes & findings →

Summary

Pilot observational study to describe the relationship between the smoking status of a psoriatic individual and the success of etanercept therapy in psoriasis treatment

Conditions

Interventions

BEHAVIORAL

smoking questionnaire

patients fill in a smoking questionnaire about their smoking habits

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192164 on ClinicalTrials.gov